Skip to main content
. 2023 Aug 25;43(10):1281–1287. doi: 10.1038/s41372-023-01762-w

Table 2.

Outcomes by HRF/PH severity category.

Mild (0–5) N = 5 Moderate (6–10) N = 65 Severe (11–15) N = 13 p value
Dichotomous outcomes, N (%)
  Death/ECLS 0 12 (18) 10 (77) <0.0001
  Required ECLS 0 8 (12) 8 (62) <0.001
  Died before discharge 0 7 (11) 7 (54) <0.001
  Required iNO 1 (20) 50 (77) 13 (100) <0.01
  Required vasoactive infusions 0 42 (65) 13 (100) <0.0001
  Required IMV 1 (20) 49 (75) 13 (100) <0.01
  Required HFOV 0 41 (84) 13 (100) 0.03
  Ventilated week or longera 0 21/42 (50) 3/6 (50) 0.72
  Ventilated 2 weeks or longera 0 7/42 (17) 3/6 (50) 0.13
  LOS over a weeka 4/5 (80) 53/58 (91) 6/6 (100) 0.31
Continuous outcomesb, median (IQR)
  Duration of iNO, hoursa 8 (8–8) 86 (57–158) 120 (58–242) 0.27
  Duration of IMV, daysa 1 (1–1) 6.5 (4–11) 9 (4–16) 0.27
  Total length of stay, daysa,b 16 (13–23) 19 (11–33) 32.5 (16–76) 0.95
  ICU length of stay, daysa 16 (13–23) 19 (11–733) 32.5 (16–51) 0.93
  VIS score 14.5 (9–27.5) 25 (15–1745) 0.17
  Duration ECLS, hoursa 106 (96–162) 152 (86–278) 0.69

iNO inhaled nitric oxide. ECLS extracorporeal life support. IMV invasive mechanical ventilation. HFOV high frequency oscillatory ventilation. VIS vasoactive-isotropic score. IQR interquartile range.

aExcludes patients that died so the denominator shown when relevant.

bp values are from linear regression comparing outcomes as continuous variables across the score categories.

Bold values indicate statistical significance.